Verition Fund Management
AKYA

Verition Fund Management’s Akoya BioSciences AKYA Stock Holding History

Verition Fund Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-166,314
Closed -$231K – 3614
2025
Q1 		$231K Buy
+166,314
New +$364K ﹤0.01% 2994
2023
Q3 		– Sell
-18,200
Closed -$134K – 2315
2023
Q2 		$134K Buy
+18,200
New +$121K ﹤0.01% 1938

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Verition Fund Management's AKYA Position: Q2 2025 in Review

Verition Fund Management sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 166,314 shares — an estimated $231K sold.

Verition Fund Management first reported a position in AKYA in Q2 2023 and held it in 2 quarters. The position peaked at $231K in Q1 2025. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Verition Fund Management reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 166,314 Akoya BioSciences shares in Q2 2025, an estimated $231K.
  • Verition Fund Management first reported a position in Akoya BioSciences in Q2 2023 and held it in 2 quarters.
  • Verition Fund Management's Akoya BioSciences position peaked at $231K in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.